Zantac
In October 2019, a class-action lawsuit was filed against Sanofi for allegedly misleadingly marketing the over-the-counter heartburn medication Zantac as safe when, according to plaintiffs, the medicine contains dangerously high levels of the carcinogen N-nitrosodimethylamine (NDMA). (Rodriguez et al v. Sanofi U.S. LLC et al, Case No. 19-cv-9527, S. D. NY.)
Class-Action Tracker
The Latest
TINA.org Tells DOT: Don’t Muddy Airline Pricing
A proposed rule change could make it harder to know what you’ll actually pay for a flight.
Carhartt: Making Football Possible
Carhartt honors the dedicated individuals who make football possible.
Tinggly
TINA.org unwraps the hidden cost of these gift boxes.
Alani Nu Facing Increased Scrutiny over Marketing to Kids
Following lawsuit, Texas AG launches probe into energy drink’s “youth-oriented branding strategies.”
Harper & Wells Boston
What you need to know about this shady e-commerce site.